DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded by StockNews.com to Buy Rating

StockNews.com upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a hold rating to a buy rating in a report published on Wednesday.

Other equities analysts have also recently issued research reports about the company. Barrington Research reiterated an “outperform” rating and set a $36.00 target price on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Evercore ISI lowered their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Stifel Nicolaus lowered their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th. Needham & Company LLC lowered their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, Robert W. Baird decreased their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a report on Monday, July 22nd. Six analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA currently has an average rating of “Hold” and an average price target of $29.50.

DENTSPLY SIRONA Stock Performance

XRAY stock opened at $17.86 on Wednesday. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. DENTSPLY SIRONA has a twelve month low of $17.21 and a twelve month high of $37.60. The business’s fifty day moving average is $24.68 and its 200-day moving average is $25.86. The company has a market cap of $3.62 billion, a P/E ratio of -8.63, a price-to-earnings-growth ratio of 1.31 and a beta of 1.02.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. During the same quarter in the prior year, the company earned $0.49 EPS. The firm’s quarterly revenue was up .4% on a year-over-year basis. Equities research analysts forecast that DENTSPLY SIRONA will post 1.98 EPS for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently bought and sold shares of XRAY. Mirae Asset Global Investments Co. Ltd. grew its holdings in DENTSPLY SIRONA by 8.7% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 40,015 shares of the medical instruments supplier’s stock worth $1,328,000 after purchasing an additional 3,219 shares during the period. Nordea Investment Management AB boosted its holdings in shares of DENTSPLY SIRONA by 6.7% during the first quarter. Nordea Investment Management AB now owns 83,898 shares of the medical instruments supplier’s stock worth $2,784,000 after acquiring an additional 5,288 shares during the period. Daiwa Securities Group Inc. boosted its holdings in shares of DENTSPLY SIRONA by 7.9% during the first quarter. Daiwa Securities Group Inc. now owns 17,652 shares of the medical instruments supplier’s stock worth $585,000 after acquiring an additional 1,296 shares during the period. Central Pacific Bank Trust Division bought a new stake in shares of DENTSPLY SIRONA during the first quarter worth approximately $64,000. Finally, GSA Capital Partners LLP bought a new stake in shares of DENTSPLY SIRONA during the first quarter worth approximately $655,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.